Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - LONG-TERM DEBT
Long-term Debt ANAB - AnaptysBio, Inc.
16 M
LAST VALUE
-9.20%
2 YEAR CAGR
91.36%
5 YEAR CAGR
0.00%
10 YEAR CAGR